Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribonucleic acid helicases are a diverse family of enzymes that use energy from nucleoside triphosphate hydrolysis (usually ATP) to unwind or remodel RNA structures and ribonucleoprotein complexes[4][5]. They play central roles in nearly every aspect of RNA metabolism, including transcription, splicing, export, translation, editing, and degradation, and their proper function is crucial for cellular adaptation to stress and for maintaining genome integrity[1][3][7]. RNA helicases are classified into multiple subfamilies, such as DEAD-box, DEAH-box, and DExD/H-box types, and further grouped into superfamilies SF1 and SF2 based on sequence and structural motifs[2][4][6]. Dysregulation of RNA helicases is implicated in cancer, viral infections, and other diseases, making selective inhibition an avenue for targeted drug development and therapeutic exploration[7].
Inhibition of ATPase activity Disruption of RNA binding or unwinding Blocking interactions with protein cofactors Modulating helicase response to viral infection or oncogenic pathways[7]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribonucleic acid helicase (RNA helicase).